Synthesis, Characterization and Cell Viability of Novel Tripodal Amines

Location

Statesboro Campus (Room 2054)

Document Type and Release Option

Thesis Presentation (Open Access)

Faculty Mentor

Dr. Christine Whitlock

Faculty Mentor Email

cwhitlock@georgiasouthern.edu

Presentation Year

2022

Start Date

16-11-2022 6:00 PM

End Date

16-11-2022 7:00 PM

Description

Cancer, over the years, has become a much more prevalent focus for the scientific community. Organizations and laboratories all over the world have spent countless hours searching for a cure, trying to learn more about what makes cancer so powerful and what is the best way to stop its growth. Iron-chelation drugs were already on the market, and it was shown that they did have the ability to act as both iron-chelators and anticancer drugs. Most of these iron-chelating drugs are not as effective at killing cancer cells as the medical field desires. Novel iron-chelating tris-indolyl derivatives, GSO2, GSO4 and GSO6, were synthesized and tested for their potential anti-cancer properties. These compounds were characterized using both melting points and NMR. Apoptosis was the chosen method for cell death of the PC3 cells. The compounds, GSO2 and GSO4 did show promising results when tested on human prostate cancer cell lines. The success of these compounds does sanction further research into apoptosis of other human cancer cell lines.

Academic Unit

College of Science and Mathematics

This document is currently not available here.

Share

COinS
 
Nov 16th, 6:00 PM Nov 16th, 7:00 PM

Synthesis, Characterization and Cell Viability of Novel Tripodal Amines

Statesboro Campus (Room 2054)

Cancer, over the years, has become a much more prevalent focus for the scientific community. Organizations and laboratories all over the world have spent countless hours searching for a cure, trying to learn more about what makes cancer so powerful and what is the best way to stop its growth. Iron-chelation drugs were already on the market, and it was shown that they did have the ability to act as both iron-chelators and anticancer drugs. Most of these iron-chelating drugs are not as effective at killing cancer cells as the medical field desires. Novel iron-chelating tris-indolyl derivatives, GSO2, GSO4 and GSO6, were synthesized and tested for their potential anti-cancer properties. These compounds were characterized using both melting points and NMR. Apoptosis was the chosen method for cell death of the PC3 cells. The compounds, GSO2 and GSO4 did show promising results when tested on human prostate cancer cell lines. The success of these compounds does sanction further research into apoptosis of other human cancer cell lines.